Zhejiang Medicine Co., Ltd.


Latest Trade






Today's Range




52 Week Range




As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Zhejiang Medicine's 9-Month Net Profit Down 30.0% Y/Y

Oct 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS 9-MONTH NET PROFIT DOWN 30.0% Y/Y AT 360.1 MILLION YUAN ($50.86 million).

Zhejiang Medicine's Net Profit Down In Q1, Up In 2018 From Year Earlier

April 23 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS 2018 NET PROFIT UP 44.0 PERCENT Y/Y.SAYS Q1 NET PROFIT DOWN 71.4 PERCENT Y/Y.

Zhejiang Medicine Plans Share Buyback Worth 50-150 Million Yuan Within Six Months

Nov 9 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS IT PLANS TO BUY BACK COMPANY SHARES WORTH 50-150 MILLION YUAN ($7.20-$21.60 million) WITHIN SIX MONTHS.

Zhejiang Medicine Says 9-Month Net Profit Up 291.4 Percent Y/Y

Oct 23 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS 9-MONTH NET PROFIT UP 291.4 PERCENT Y/Y.

Zhejiang Medicine to pay 2017 A shares dividend on July 19

July 12(Reuters) - Zhejiang Medicine Co Ltd <600216.SS>:Says it will pay a cash dividend of 0.08 yuan per share (before tax) for 2017, to shareholders of A shares recorded on July 18.Says the company's shares will be traded ex-right and ex-dividend on July 19 and the dividend will be paid on July 19 .

Zhejiang Medicine Says Board Elects Li Chunbo As Chairman

June 15 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS BOARD ELECTS LI CHUNBO AS CHAIRMAN.

Zhejiang Medicine's 2017 Net Profit Down, Q1 Net Profit Up

April 24 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS 2017 NET PROFIT DOWN 43.8 PERCENT Y/Y AT 253.1 MILLION YUAN ($40.13 million).SAYS Q1 NET PROFIT UP 1,838.1 PERCENT Y/Y AT 465.3 MILLION YUAN.

Zhejiang Medicine 's 2017 Preliminary Net Profit Down, But Sees Q1 Net Profit Surging

March 12 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS ITS PRELIMINARY 2017 NET PROFIT DOWN 41.52 PERCENT Y/Y AT 263.2 MILLION YUAN ($41.62 million).SAYS IT SEES Q1 NET PROFIT UP 1,815.81-2,190.65 PERCENT Y/Y AT 435.99-525.99 MILLION YUAN.

Zhejiang Medicine passes review of high-tech enterprise recognition

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years.

Zhejiang Medicine terminates clinical trial for a kind of antitumor drug

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it decided to terminate clinical trials for a kind of antitumor drug (R&D code name of XC302).

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.